Journal of Clinical Endocrinology & Metabolism, Vol 76, 1106-1110, Copyright © 1993 by Endocrine Society

ARTICLES

Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium

BJ Vollenhoven, AC Herington and DL Healy
Department of Obstetrics and Gynecology, Monash University, Monash Medical Centre, Clayton, Victoria, Australia.

Fibroids (leiomyomata) are the most common tumors in women, but their etiology is unknown. The insulin-like growth factors (IGFs) and their binding proteins (IGFBPs) may be important in the growth of these benign neoplasms. We have examined the presence of mRNA encoding both IGF-I and IGF-II and IGFBP-1, -2, and -3 in fibroids and corresponding myometrium from 20 women undergoing hysterectomy for symptomatic uterine fibroids. Northern blots of total cellular RNA were probed with oligonucleotides for IGF-I, IGF-II, IGFBP-2, and IGFBP-3 and a human IGFBP-1 cDNA. Western ligand blotting was also used to detect the presence of IGFBP proteins in both fibroid and myometrium. The data showed that in fibroids compared to myometrium, 1) the relative abundance of IGF-I mRNA was not different, but there was an increase in the relative abundance of IGF-II mRNA (P < 0.001); 2) IGFBP-1 mRNA was undetectable in fibroids and detectable in only 1 specimen of myometrium; 3) there was no difference in the relative abundance of IGFBP-2 mRNA, but there was an increase in the relative abundance of IGFBP-3 mRNA in myometrium (P < 0.05). By Western ligand blotting, both IGFBP-2 and -3 proteins were present. Our data show that the mRNAs encoding IGF-I, IGF-II, IGFBP-2, and IGFBP-3 are expressed in both fibroids and myometrium and that fibroids express more IGF-II and less IGFBP-3 mRNA than myometrium. We postulate that the net effect of the changes seen is to increase the bioavailability of free (bioactive) IGF, which may then play a major role in promoting fibroid tumor growth.

This article has been cited by other articles:

				H. Ishikawa, M. Shozu, M. Okada, M. Inukai, B. Zhang, K. Kato, T. Kasai, and M. Inoue Early growth response gene-1 plays a pivotal role in down-regulation of a cohort of genes in uterine leiomyoma J. Mol. Endocrinol., November 1, 2007; 39(5): 333 - 341. [Abstract] [Full Text] [PDF]

				A. A. Arslan, L. I. Gold, K. Mittal, T.-C. Suen, I. Belitskaya-Levy, M.-S. Tang, and P. Toniolo Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review Hum. Reprod., April 1, 2005; 20(4): 852 - 863. [Abstract] [Full Text] [PDF]

				T. Kanamori, K. Takakura, M. Mandai, M. Kariya, K. Fukuhara, M. Sakaguchi, N.-h. Huh, K. Saito, T. Sakurai, J. Fujita, et al. Increased expression of calcium-binding protein S100 in human uterine smooth muscle tumours Mol. Hum. Reprod., October 1, 2004; 10(10): 735 - 742. [Abstract] [Full Text] [PDF]

				T. Maruo, N. Ohara, J. Wang, and H. Matsuo Sex steroidal regulation of uterine leiomyoma growth and apoptosis Hum. Reprod. Update, May 1, 2004; 10(3): 207 - 220. [Abstract] [Full Text] [PDF]

				F. Philippoussis, D. Gagne, P. Hugo, and D. Gosselin Concentrations of Alpha-Fetoprotein, Insulin-Like Growth Factor Binding Protein-3, c-erbB-2, and Epidermal Growth Factor in Serum of Patients With Endometriosis Reproductive Sciences, April 1, 2004; 11(3): 175 - 181. [Abstract] [PDF]

				T. Kanamori, K. Takakura, M. Mandai, M. Kariya, K. Fukuhara, T. Kusakari, C. Momma, H. Shime, H. Yagi, M. Konishi, et al. PEP-19 overexpression in human uterine leiomyoma Mol. Hum. Reprod., November 1, 2003; 9(11): 709 - 717. [Abstract] [Full Text] [PDF]

				G. Weston, A. C. Trajstman, C. E. Gargett, U. Manuelpillai, B. J. Vollenhoven, and P. A.W. Rogers Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium Mol. Hum. Reprod., September 1, 2003; 9(9): 541 - 549. [Abstract] [Full Text] [PDF]

				D. Sampath, Y. Zhu, R. C. Winneker, and Z. Zhang Aberrant Expression of Cyr61, a Member of the CCN (CTGF/Cyr61/Cef10/NOVH) Family, and Dysregulation by 17{beta}-Estradiol and Basic Fibroblast Growth Factor in Human Uterine Leiomyomas J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1707 - 1715. [Abstract] [Full Text]

				K. Englund, B. Lindblom, K. Carlstrom, I. Gustavsson, P. Sjoblom, and A. Blanck Gene expression and tissue concentrations of IGF-I in human myometrium and fibroids under different hormonal conditions Mol. Hum. Reprod., October 1, 2000; 6(10): 915 - 920. [Abstract] [Full Text] [PDF]

				R. Casey, P.A.W. Rogers, and B.J. Vollenhoven An immunohistochemical analysis of fibroid vasculature Hum. Reprod., July 1, 2000; 15(7): 1469 - 1475. [Abstract] [Full Text] [PDF]

				S. Hague, L. Zhang, M. K. Oehler, S. Manek, I. Z. MacKenzie, R. Bicknell, and M. C. P. Rees Expression of the Hypoxically Regulated Angiogenic Factor Adrenomedullin Correlates with Uterine Leiomyoma Vascular Density Clin. Cancer Res., July 1, 2000; 6(7): 2808 - 2814. [Abstract] [Full Text]

				O. O. Adesanya, J. Zhou, C. Samathanam, L. Powell-Braxton, and C. A. Bondy Insulin-like growth factor 1 is required for G2 progression in the estradiol-induced mitotic cycle PNAS, March 16, 1999; 96(6): 3287 - 3291. [Abstract] [Full Text] [PDF]

				B.-S. Lee, S. B. Margolin, and R. A. Nowak Pirfenidone: A Novel Pharmacological Agent That Inhibits Leiomyoma Cell Proliferation and Collagen Production J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 219 - 223. [Abstract] [Full Text]

				J. Andersen and R. L. Barbieri Abnormal Gene Expression in Uterine Leiomyomas Reproductive Sciences, September 1, 1995; 2(5): 663 - 672. [Abstract] [PDF]